Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology) - Image 1

£107.98

Springer Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)

Name: Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)
Brand: Springer
Price: 107.98 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 57 days • 57 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 57 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £108 (41 days, 71.9%)

Price range: £107 - £108

Price levels: 2 different prices over 57 days

Description

Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3642641407
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 18 September 2011
Listed Since: 13 July 2012

Barcode

No barcode data available

Springer Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research)

The Molecular Genetics of Lung Cancer

Molecular Targeted Therapy of Lung Cancer

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)

Pulmonary Disease: Pathology, Radiology, Bronchoscopy

Inflammation and Lung Cancer

Decision Tools for Radiation Oncology: Prognosis, Treatment Response and Toxicity (Medical Radiology)

Management of Lung Cancer in Older People

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Management of Lung Cancer in Older People

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Functional Preservation and Quality of Life in Head and Neck Radiotherapy (Medical Radiology)

Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Lung Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-3 (The Clinics: Internal Medicine, Volume 37-3)

Prognostic variables in node-negative and node-positive breast cancer

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)